Skip to main content

Table 2 Median uPA/PAI-1 levels in tumour populations

From: Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

  uPA−/PAI-1+ uPA+/PAI-1+ uPA +/PAI-1- uPA−/PAI-1-
Number of patients 85 92 35 135
Median level of uPA (ng/mg; min-max) 1.7 (0.19–2.9) 4.7 (3.0–12.9) 4.7 (3–7.3) 1.2 (0.0–2.9)
Median level of PAI-1 (ng/mg; min-max) 21.1 (14.0–87.8) 22.6 (14.0–130) 9.56 (5.5–13.8) 6.7 (2.9–10.6)
  1. uPA+: uPA ≥3 ng/mg; uPA-: < 3 ng/mg; PAI-1+: ≥14 ng/mg; PAI-1-: <14 ng/mg